Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) in patients 8 years of age or ...
Janus kinase (JAK) inhibitors, including baricitinib, block cytokine signaling and are effective disease-modifying treatments for several autoimmune diseases. Whether baricitinib preserves β-cell ...
Whether it's an early morning jog, or a touch of Tai Chi, groundbreaking research shows that any form of exercise can significantly boost brain function and memory across children, adults, and older ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback